A multicenter, randomized trial of posaconazole (POS) vs fluconazole (FLU) or itraconazole (ITZ) for prophylaxis of invasive fungal infections (IFIs) in neutropenic patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) receiving intensive chemotherapy
D.J. Winston, O.A. Cornely, J. Maertens, J. Perfect, D. Helfgott, A.J. Ullmann, J. Holowiecki, D. Stockelberg, Y.-T. Goh, M. Petrini, T.J. Walsh, C. Hardalo, D. Angulo-GonzalezVolume:
12
Year:
2006
Language:
english
DOI:
10.1016/j.bbmt.2005.11.431
File:
PDF, 70 KB
english, 2006